Both a call to action and a roadmap for progress, Families USA’s latest report, Health Reform 2.0 lays out a path for securing high-quality, affordable health care to all Americans—regardless of income, age, race, or ethnicity—and for achieving the “Triple Aim”: improving health, enhancing quality of care, and reducing health care costs.
Consumers, employers, and policymakers all need greater transparency in health care pricing. Learn what federal and state policymakers can do to improve access to health care price information.
Early last week, Health and Human Services Secretary Sylvia Burwell announced a new initiative designed to support state efforts to improve the health of Medicaid beneficiaries and the care they receive.
As part of the Medicaid Innovation Accelerator Program (IAP), the Center for Medicare Services (CMS) will develop new resources for and provide technical assistance to states engaged in efforts to reform their Medicaid programs. The IAP seeks to achieve the triple aim of better care, better health outcomes, and lower costs.
New Survey Finds That Most Consumers Oppose Penalties in Employee Health Insurance Wellness Programs
Earlier today, the Kaiser Family Foundation released findings from a new survey on consumer sentiment around the role of employee wellness programs. The poll found that, while 76 percent of the public supports employers offering wellness programs that promote healthy behaviors, the majority of consumers (75 percent) are opposed to employers charging higher premiums if workers don’t meet the health goals of their workplace wellness program.
Our infographic shows how a consumer’s costs vary depending on the provider he or she chooses for a sample medical procedure that is subject to reference pricing.
Explains how reference pricing programs, when implemented in consumer-friendly ways, can minimize price variation and encourage consumers to shop for care based on price and quality.
Although the Affordable Care Act now offers individuals greatly expanded access to health coverage, simply having an insurance card does not guarantee access to high-quality health care.
Live updates from day 2 of Health Action 2014.
Doctors and Drug Company Dollars: How Recent Strides toward Transparency in Financial Relationships Will Benefit Consumers
GlaxoSmithKline, one of the world's largest pharmaceutical manufacturers, made a bold announcement this week: It's going to stop paying doctors to promote its drugs. In an industry that has long relied on physicians to spread the word to their colleagues about new medicines (and has compensated them handsomely for doing so), this marks what many hope is the beginning of a major change in the culture of medicine and the marketing of drugs.
Explains value-based insurance design and high-value care, outlines the key elements that value-based insurance should include.